• SENSEX 76,718.56
    148.21 (+0.19%)
  • BANKNIFTY 57,172.00
    -237.60 (--0.41%)
  • Power Fin.Corpn.
    351.60 486.45(%)
  • Netweb Technol.
    5,347.65 5,810.00(%)
  • Antelopus Selan
    1,035.95 951.45(%)
  • IFCI
    101.60 99.45(%)
  • HDFC Bank
    712.75 1,020.35(%)
  • Godrej Consumer
    859.50 891.10(%)
  • Max Healthcare
    988.00 903.50(%)
  • Milky Mist Dairy
    268.75 255.10(%)
  • Divi's Lab.
    9,277.55 9,296.00(%)
  • Solar Industries
    21,569.40 20,760.15(%)
  • Ather Energy
    1,630.00 481.25(%)
  • Elgi Equipments
    629.30 643.30(%)
  • Energy InfrTrust
    74.25 102.00(%)
  • Bharat Dynamics
    1,266.45 1,655.25(%)
  • Jyoti CNC Auto.
    999.00 1,055.00(%)
  • Coal India
    428.40 490.90(%)
  • Welspun Corp
    2,675.00 2,593.15(%)
  • Anant Raj
    634.60 744.10(%)
  • RBL Bank
    409.00 397.95(%)
  • Multi Comm. Exc.
    3,180.35 1,496.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Parmax Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 6620.0
  • ISIN : INE240T01014
132.45 1 (0.99%)
  • As on 03 Sep 2026 (EOD)

  • Today’s Low

    132.45

  • Today’s High

    132.45

  • Open

    132.45

  • Perv Close

    131.15

  • 52W Low

    22.60

  • 52W High

    132.45

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    91.11

  • Div & Yield %

    0.00

  • Book Value(₹)

    6.68

  • Debt-Equity Ratio

    0.99

  • AGM Date

    31-Aug-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    91.11

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.88

  • BV (₹)

    6.70

  • Sales( ₹ in Cr.)

    12.11

  • NP (in Cr.)

    -4.16

  • NP Var(%)

    -307.0

  • Div%

    0.0

  • CPS (₹)

    -4.60

  • EPS (₹)

    -6.00

  • Traded Value (₹ in Lakhs)

    91.11

  • 52 Week High

    132.45

  • 52 Week Low

    22.60

  • Price BSE

    132.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    91.11

  • P/C Ratio

    -28.90

  • P/E Ratio

    -21.80

  • Price Vs.BV

    -6.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 28.20 11.05 15.42 18.25 26.20 20.93
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.01
Net Sales 28.20 11.05 15.42 18.25 26.20 20.92
Other Income 0.04 0.05 0.04 0.06 0.09 0.10
Stock Adjustments 0.00 -0.02 0.02 -0.43 0.52 -1.47
Total Income 28.24 11.08 15.48 17.88 26.81 19.55
EXPENDITURE :            
Raw Materials 21.54 7.03 5.51 6.29 13.96 9.79
Power and Fuel Cost 1.90 2.30 1.98 2.31 2.09 2.26
Employee Cost 2.99 2.91 2.80 3.46 3.54 2.91
Other Manufacturing Expenses 0.37 1.03 1.53 1.66 2.13 1.37
Selling and Administration Expenses 1.01 0.67 0.87 1.03 0.95 0.70
Miscellaneous Expenses 1.22 0.47 0.50 0.52 0.63 0.64
Employee Benefit Expenses 2.99 2.91 2.80 3.46 3.54 2.91
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 29.03 14.40 13.19 15.27 23.30 17.67
Operating Profit -0.77 -3.32 2.29 2.63 3.52 1.87
Interest 0.59 0.62 0.37 0.39 0.37 0.13
Gross Profit -1.36 -3.94 1.92 2.24 3.15 1.74
Depreciation 1.03 1.71 1.88 1.93 1.94 1.01
Profit Before Tax -2.39 -5.65 0.04 0.31 1.21 0.73
Current Tax 0.00 0.13 0.19 0.22 0.30 0.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.30 -0.03 -0.04 -0.05 0.16 0.15
Reported Net Profit -2.09 -5.75 -0.10 0.14 0.75 0.43
Extraordinary Items -1.07 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -1.02 -5.75 -0.10 0.14 0.75 0.43
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -4.35 1.40 1.51 1.37 0.61 0.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -6.44 -4.35 1.40 1.51 1.37 0.61
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -4.70 -12.92 -0.23 0.32 1.69 0.96
Earnings Per Share(Adj)-Unit Curr -4.70 -12.92 -0.23 0.32 1.69 -
Book Value -4.47 0.24 13.16 13.39 13.07 11.38
Book Value(Adj)-Unit Curr -4.47 0.24 13.16 13.39 13.07 -

Shareholding Pattern

  • Promoter Group

    30.80%

  • Public Share Holding

    69.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,152,450 30.80 1,152,450 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,152,450 30.80 1,152,450 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 6,030 0.16 4,430 7
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 252,144 6.74 252,144 12
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 26,197 0.70 16,197 18
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 797,720 21.32 797,720 9
Individuals holding nominal share capital up to Rs. 1 lakh 1,306,758 34.93 367,428 2,222
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 200,000 5.35 200,000 1
Sub Total 2,588,850 69.20 1,637,920 2,270
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,741,300 100.00 2,790,370 2,273

Company Background

Parmax Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Parmax Pharma Ltd
  • BSE Code : 6620.0
  • ISIN : INE240T01014

  • Incorporation Year

    1994

  • Registered Office

    Plot No 20 Survey No 52
    Tal Kotda Sangani Hadamtala, Rajkot,
    Gujarat-360311

  • Telephone

    91-2827-270534/535

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    B A Shah S R Mehta & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Parmax Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Parmax Pharma 132.45 28.24 28.20 -76.12 0.00
Abbott India 26,025.15 7,217.19 6,929.05 34.25 43.78
Astrazeneca Phar 6,870.25 2,304.07 2,275.58 101.26 27.86
Glaxosmi. Pharma 2,946.60 3,932.76 3,790.20 47.07 58.17
Novartis India 1,602.15 398.23 356.27 40.46 16.64
Cipla 1,413.15 20,102.60 18,979.95 37.14 13.88
Bliss GVS Pharma 649.00 773.53 729.81 60.26 12.51
Fermenta Biotec. 522.75 474.15 450.25 24.40 18.77
Amrutanjan Healt 501.90 520.13 502.55 26.88 24.16
Guj. Themis Bio. 412.60 152.47 150.80 110.32 27.21
Ambalal Sarabhai 44.79 19.52 3.94 82.94 6.77